For a three-month multi-site randomized double-blind placebo-controlled study to assess safety and efficacy of hydroxy-chloroquine (HCQ) Pre-exposure Prophylaxis (PrEP) in the prevention of COVID-19 infections in high-risk Health Care Workers.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Kevin KainResearch Location
CanadaLead Research Institution
University Health NetworkResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Clinical trial (unspecified trial phase)Special Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Randomized Controlled TrialBroad Policy Alignment
PendingAge Group
Adults (18 and older)Vulnerable Population
UnspecifiedOccupations of Interest
Unspecified